Class Nine Companies
Ten startup health-tech companies from across the United States are joining us from September to December 2023 as part of the eight class of the Cedars-Sinai Accelerator. This year's startup companies are creating high-tech solutions to a wide variety of healthcare challenges. Chosen from hundreds of startups, these ten teams and their innovative products represent the best and brightest from our global community of health innovators.
You can also learn about our 80+ alumni companies.
52North develops platform technology that adapts lateral flow to create a low-cost method of measuring both cells and solutes from a single sample.
52North’s solution - Neutrocheck® - is a finger-prick blood test and digital platform aimed at disrupting the clinical pathway for diagnosis and treatment of the most fatal side-effect of chemotherapy treatment: a condition called neutropenic sepsis. Neutrocheck enables rapid at-home identification of cancer patients on chemotherapy who are truly at risk of sepsis.
Acorai develops a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM) to help reduce hospitalizations and improve quality of life for heart failure patients.
The Acorai Heart Monitor monitors the intracardiac pressures non-invasively through its proprietary SAVE Sensor System, leveraging machine learning analysis of Seismic, Acoustic, Visual and Electrocardiographic data.
Alva Health develops a device that uses non-invasive wearables and machine learning algorithms to monitor the onset of stroke symptoms and immediately initiate emergency calls. The wearable platform detects hemiparesis, a hallmark of stroke onset. Upon the onset of hemiparesis, the user is connected to a 24/7 call center where trained medical responders perform additional assessments and initiate 911 calls when indicated.
Alva Health’s goal is to build a game-changing solution for the early detection of stroke symptoms, which will enable for the first time the automated, seamless monitoring of stroke in high risk patients at home, and away from the hospital where they are most vulnerable.
CARI Health develops a wearable remote medication monitor to enable personalized dosing and adherence monitoring. CARI’s solution combines proprietary core sensing technology with software, mobile apps, data, and AI to measure medication levels in real-time.
Along with its initial focus on monitoring methadone patients in opioid use disorder treatment, CARI Health plans to expand to additional use cases where personalized medication dosing and adherence monitoring has high value. Combining personalized dosing with the ability for patients to prove adherence remotely will make therapeutic treatment more compelling for new patients, more convenient for current patients, and result in longer adherence, all at a lower total cost of care for payers.
equalityMD is a LGBTQ+ culturally competent, digital healthcare and data analytics B2B SaaS platform for health systems, employers, and individuals. The telehealth platform trains providers to be LGBTQ+ culturally competent, matches patients with trained providers, and delivers patient-centric care to a growing NIH designated “health disparity population.”
While the platform focusses on mental health and primary care, it also offers services such as wellness services, medication management, nutrition guidance, and more.
Machine Medicine's flagship product, Kelvin, is a video-based motor assessment platform for movement disorders. This proprietary software utilizes a unique dataset of clinician-labelled videos, exclusive to Machine Medicine.
With Kelvin, anyone can perform remote motor assessments using their smartphone. The platform empowers researchers to record, score, store, and analyze videos of patients with movement disorders such as Parkinson's Disease, during motor assessments.
A key feature of Kelvin is its implementation of advanced computer vision techniques, particularly pose estimation. This state-of-the-art technology enables the platform to accurately track patients' movements down to the finest details. By doing so, it delivers objective metrics for core symptoms like tremor and bradykinesia, allowing treatment to be individually tailored.
Paperplane Therapeutics offers cognitive behavioral therapies in the form of highly interactive virtual reality to better manage the pain and anxiety of patients receiving care. The company's clinically validated solutions are purpose-built for patients of all ages, with a strong focus on pediatrics.
Paperplane Therapeutics provides a turnkey solution that tackles everything from hardware and software to fleet management and training, making it easy for healthcare professionals to use and patients to benefit from.
Predicta Med is a healthcare technology company that provides a proprietary decision support platform for early identification and guideline-based intervention recommendation for patients with undiagnosed immune-related diseases.
Predicta Med’s deep learning engine aggregates electronic medical records and claims data, enriching and analyzing this data with state-of-the-art learning techniques.
The platform utilizes machine learning to predict a patient's risk of having an undiagnosed immune-related condition and provides guideline-based recommendations for primary care physicians.
RCE.ai is an AI med-tech company that develops the world's only non-invasive continuous troponin monitoring wearable for detecting early stages of heart attacks.
Monitoring cardiac proteins in the blood, RCE.ai’s device empowers emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain.
TestDynamics provides a platform offering hospitals and physicians one-stop, intelligent access to a wide range of AI models. The company’s mission is to revolutionize the use of AI in the field of medical imaging and diagnostics.
TestDynamics develops Satori, an innovative platform designed to serve as a bridge between AI algorithms and healthcare providers. Satori offers a seamless integration of thousands of AI algorithms, automated workflows, and a user-friendly interface into the mainstream medical workflow.
By incorporating medical imaging AI algorithms into the regular workflow through a single integration point, TestDynamics aims to enhance patient care outcomes, boost physician productivity, reduce healthcare costs, and lower malpractice risks.
